SIGGILLINO, ANNAMARIA
SIGGILLINO, ANNAMARIA
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr
2020 Siggillino, A.; Ulivi, P.; Pasini, L.; Reda, M. S.; Chiadini, E.; Tofanetti, F. R.; Baglivo, S.; Metro, G.; Crino, L.; Delmonte, A.; Minotti, V.; Roila, F.; Ludovini, V.
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
2015 Baldelli, Elisa; Bellezza, Guido; Haura, Eric B.; Crino', Lucio; Cress, W. Douglas; Deng, Jianghong; Ludovini, Vienna; Sidoni, Angelo; Schabath, Matthew B.; Puma, Francesco; Vannucci, Jacopo; Siggillino, Annamaria; Liotta, Lance A.; Petricoin, Emanuel F.; Pierobon, Mariaelena
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis
2016 Ludovini, Vienna; Bianconi, Fortunato; Siggillino, Annamaria; Piobbico, Danilo; Vannucci, Jacopo; Metro, Giulio; Chiari, Rita; Bellezza, Guido; Puma, Francesco; Della Fazia, Maria Agnese; Servillo, Giuseppe; Crino', Lucio
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
2021 Ludovini, V.; Bianconi, F.; Siggillino, A.; Vannucci, J.; Baglivo, S.; Berti, V.; Tofanetti, F. R.; Reda, M. S.; Bellezza, G.; Mandarano, M.; Belladonna, M. L.; Metro, G.; Chiari, R.; Sidoni, A.; Puma, F.; Minotti, V.; Roila, F.
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy
2021 Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F. R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.; Reda, M. S.; Chiari, R.; Pistola, L.; Sidoni, A.; Minotti, V.; Roila, F.; Ludovini, V.
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype
2012 Metro, G; Chiari, R; Duranti, S; Siggillino, Annamaria; Fischer, Mj; Giannarelli, D; Ludovini, V; Bennati, C; Marcomigni, L; Baldi, A; Giansanti, M; Minotti, V; Crino', Lucio
KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts)
2012 Metro, G; Duranti, S; Chiari, R; Bennati, C; Molica, C; Curra, Mf; Scafati, C; Siggillino, Annamaria; Flacco, A; Marcomigni, L; Ludovini, V; Minotti, V; Crino', Lucio
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer
2017 Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita
Liquid Biopsy in early Breast Cancer: A preliminary Report
2020 Rulli, Antonio; Antognelli, Cinzia; Siggillino, Annamaria; Zayik, Svitlana; Izzo, Luciano; Covarelli, Piero; Talesa, Vincenzo Nicola; Ludovini, Vienna
Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations
2018 Ricciuti, Biagio; Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Brambilla, Marta; Siggillino, Annamaria; Reda, Maria Sole; Rebonato, Alberto; Maiettini, Daniele; Chiari, Rita
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer
2016 Cagini, Lucio; Marinucci, Lorella; Ludovini, Vienna; Andolfi, M.; Potenza, R.; Balloni, Stefania; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, F. R.; Bellezza, Guido; Bodo, Maria; Puma, Francesco
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition
2013 Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M.
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients
2011 Ludovini, Vienna; Bianconi, Fortunato; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Baldelli, E; Minotti, V; Ragusa, Mark; Vannucci, Jacopo; Treggiari, S; Bennati, C; Colella, Renato; Bigio, F; Puma, Francesco; Crino, L.
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study
2017 Ludovini, V; Chiari, R; Tomassoni, L; Antonini, C; Baldelli, E; Baglivo, S; Siggillino, A; Tofanetti, Fr; Bellezza, G; Hodge, Ka; Petricoin, E; Pierobon, M; Crinò, L; Bianconi, F.
Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients.
2014 Crino', Lucio; Ludovini, V; Siggillino, Annamaria; Bianconi, Fortunato; Tofanetti, F. R.; Pistola, L; Metro, G; Ragusa, Mark; Sidoni, Angelo; Puma, Francesco
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations
2021 Metro, G.; Baglivo, S.; Bellezza, G.; Mandarano, M.; Gili, A.; Marchetti, G.; Toraldo, M.; Molica, C.; Reda, M. S.; Tofanetti, F. R.; Siggillino, A.; Prosperi, E.; Giglietti, A.; Di Girolamo, B.; Garaffa, M.; Marasciulo, F.; Minotti, V.; Gunnellini, M.; Guida, A.; Sassi, M.; Sidoni, A.; Roila, F.; Ludovini, V.
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer
2017 Cagini, Lucio; Balloni, Stefania; Ludovini, Vienna; Andolfi, Marco; Matricardi, Alberto; Potenza, Rossella; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, Francesca Romana; Bellezza, Guido; Bodo, Maria; Puma, Francesco; Marinucci, Lorella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr | 2020 | Siggillino, A.; Ulivi, P.; Pasini, L.; Reda, M. S.; Chiadini, E.; Tofanetti, F. R.; Baglivo, S.; Metro, G.; Crino, L.; Delmonte, A.; Minotti, V.; Roila, F.; Ludovini, V. | |
| Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors | 2015 | Baldelli, Elisa; Bellezza, Guido; Haura, Eric B.; Crino', Lucio; Cress, W. Douglas; Deng, Jianghong; Ludovini, Vienna; Sidoni, Angelo; Schabath, Matthew B.; Puma, Francesco; Vannucci, Jacopo; Siggillino, Annamaria; Liotta, Lance A.; Petricoin, Emanuel F.; Pierobon, Mariaelena | |
| Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis | 2016 | Ludovini, Vienna; Bianconi, Fortunato; Siggillino, Annamaria; Piobbico, Danilo; Vannucci, Jacopo; Metro, Giulio; Chiari, Rita; Bellezza, Guido; Puma, Francesco; Della Fazia, Maria Agnese; Servillo, Giuseppe; Crino', Lucio | |
| High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients | 2021 | Ludovini, V.; Bianconi, F.; Siggillino, A.; Vannucci, J.; Baglivo, S.; Berti, V.; Tofanetti, F. R.; Reda, M. S.; Bellezza, G.; Mandarano, M.; Belladonna, M. L.; Metro, G.; Chiari, R.; Sidoni, A.; Puma, F.; Minotti, V.; Roila, F. | |
| Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy | 2021 | Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F. R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.; Reda, M. S.; Chiari, R.; Pistola, L.; Sidoni, A.; Minotti, V.; Roila, F.; Ludovini, V. | |
| Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype | 2012 | Metro, G; Chiari, R; Duranti, S; Siggillino, Annamaria; Fischer, Mj; Giannarelli, D; Ludovini, V; Bennati, C; Marcomigni, L; Baldi, A; Giansanti, M; Minotti, V; Crino', Lucio | |
| KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts) | 2012 | Metro, G; Duranti, S; Chiari, R; Bennati, C; Molica, C; Curra, Mf; Scafati, C; Siggillino, Annamaria; Flacco, A; Marcomigni, L; Ludovini, V; Minotti, V; Crino', Lucio | |
| Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer | 2017 | Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita | |
| Liquid Biopsy in early Breast Cancer: A preliminary Report | 2020 | Rulli, Antonio; Antognelli, Cinzia; Siggillino, Annamaria; Zayik, Svitlana; Izzo, Luciano; Covarelli, Piero; Talesa, Vincenzo Nicola; Ludovini, Vienna | |
| Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations | 2018 | Ricciuti, Biagio; Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Brambilla, Marta; Siggillino, Annamaria; Reda, Maria Sole; Rebonato, Alberto; Maiettini, Daniele; Chiari, Rita | |
| Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer | 2016 | Cagini, Lucio; Marinucci, Lorella; Ludovini, Vienna; Andolfi, M.; Potenza, R.; Balloni, Stefania; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, F. R.; Bellezza, Guido; Bodo, Maria; Puma, Francesco | |
| Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition | 2013 | Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M. | |
| Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients | 2011 | Ludovini, Vienna; Bianconi, Fortunato; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Baldelli, E; Minotti, V; Ragusa, Mark; Vannucci, Jacopo; Treggiari, S; Bennati, C; Colella, Renato; Bigio, F; Puma, Francesco; Crino, L. | |
| Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study | 2017 | Ludovini, V; Chiari, R; Tomassoni, L; Antonini, C; Baldelli, E; Baglivo, S; Siggillino, A; Tofanetti, Fr; Bellezza, G; Hodge, Ka; Petricoin, E; Pierobon, M; Crinò, L; Bianconi, F. | |
| Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients. | 2014 | Crino', Lucio; Ludovini, V; Siggillino, Annamaria; Bianconi, Fortunato; Tofanetti, F. R.; Pistola, L; Metro, G; Ragusa, Mark; Sidoni, Angelo; Puma, Francesco | |
| Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations | 2021 | Metro, G.; Baglivo, S.; Bellezza, G.; Mandarano, M.; Gili, A.; Marchetti, G.; Toraldo, M.; Molica, C.; Reda, M. S.; Tofanetti, F. R.; Siggillino, A.; Prosperi, E.; Giglietti, A.; Di Girolamo, B.; Garaffa, M.; Marasciulo, F.; Minotti, V.; Gunnellini, M.; Guida, A.; Sassi, M.; Sidoni, A.; Roila, F.; Ludovini, V. | |
| Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer | 2017 | Cagini, Lucio; Balloni, Stefania; Ludovini, Vienna; Andolfi, Marco; Matricardi, Alberto; Potenza, Rossella; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, Francesca Romana; Bellezza, Guido; Bodo, Maria; Puma, Francesco; Marinucci, Lorella |